Cambrex op income doubles on increased API sales
Cambrex’ operating income more than doubled in the fourth quarter as a result of an upturn in API sales and lower production costs.
Archives for February 14, 2011
Merck producing human interferon beta for Nuron
The Merck BioManufacturing Network is producing clinical supplies for Nuron Biotech using a novel large scale pressure refold technology.
Pragmatic, real-world trials will bring treatments to patients
Adoption of a pragmatic, real-world research culture would bridge the gap between discovery and treating the intended patients.
Batch variation has implications for developing world
Variation between drug batches in developing countries poses “serious clinical implications” and should be tackled by regulators.
QPS buys tox and preclinical testing capacity in Taiwan
QPS Holdings has acquired Taiwan’s Center of Toxicology and Preclinical Sciences (CTPS), continuing its expansion in the region’s rapidly expanding drug development sector.
Elan announces therapeutics deal with Boehringer
Elan has entered into a development and manufacturing agreement with German pharmaceutical company, Boehringer Ingelheim, for antibody-based therapeutics.